Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001571049-16-014575
Filing Date
2016-04-29
Accepted
2016-04-29 17:30:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 FORM S-3 t1601155-s3.htm S-3 442096
2 EXHIBIT 5.1 t1601155_ex5-1.htm EX-5.1 37920
3 EXHIBIT 23.1 t1601155_ex23-1.htm EX-23.1 2182
4 GRAPHIC logoex5-1.jpg GRAPHIC 5848
  Complete submission text file 0001571049-16-014575.txt   491483
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-211046 | Film No.: 161608633
SIC: 2834 Pharmaceutical Preparations